Back to Market返回行情

DHR Danaher Corporation

USHealthcare
$195.98+2.73%ClosedMarket Cap: $138.71B

As of 2026-07-09 16:00

Why DHR matters now

Danaher Corporation (DHR) is a US stock in Healthcare. The latest InvestLog snapshot shows $195.98 with +2.73% on the session and $138.71B in market capitalization; recent performance reads 1-month +6.06% and YTD -22.61%.

The latest financial table shown here is Q1 2026, with revenue of $5.95B, net income of $1.03B, and EPS of $1.45. Investors can compare that operating picture with valuation signals such as P/E 37.10 and FCF yield 4.2%.

The latest indexable market news headline is "VTRS or DHR: Which Is the Better Value Stock Right Now?" from Zacks Investment Research.

Additional event context on this page matters because analyst consensus is Buy with a median target of $230.00; recent insider activity includes Lamanna Charles W filing A-Award; recent congressional disclosure data includes Michael McCaul Purchase. These signals are research inputs, not a recommendation.

Valuation

P/E (TTM)

37.10

PEG

P/B

2.37

P/S

5.06

EV/EBITDA

20.80

DCF Value

$223.00

FCF Yield

4.2%

Div Yield

0.8%

Margins & Returns

Gross Margin

60.7%

Operating Margin

21.0%

Net Margin

14.9%

ROE

7.1%

ROA

4.4%

ROIC

5.7%

Financials

PeriodRevenueNet IncomeEPS
Q1 2026$5.95B$1.03B$1.45
Q4 2025$6.84B$1.20B$1.68
FY 2025$24.57B$3.61B$5.04
Q3 2025$6.05B$908.0M$1.27

Analyst Ratings

Consensus

Buy

Target (Consensus)

$230.89

Target (Median)

$230.00

Target Range

$200.00 - $265.00

Strong Buy: 4Buy: 19Hold: 4Sell: 0Strong Sell: 0
Piper SandlerNeutral
2026-06-11
HSBCBuy
2026-06-03
CitigroupNeutral
2026-05-27
Morgan StanleyOverweight
2026-04-23
GuggenheimBuy
2026-04-22

Trading Activity

Insider Trades

Lamanna Charles Wdirector
Sell2026-05-19
Lamanna Charles Wdirector
Sell2026-05-19
Dewan Ferozdirector
Sell2026-05-19
Dewan Ferozdirector
Sell2026-05-19
Zerhouni Elias A.director
Sell2026-05-19

Congress Trades

Michael McCaulBuy
2026-05-11
Michael McCaulBuy
2026-04-10

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

US

Exchange

Beta

0.83

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.